A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Mayo Clinic
NRG Oncology
University of Washington
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
University Hospital Heidelberg
University Hospital Heidelberg
Jonsson Comprehensive Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
Mayo Clinic
Mayo Clinic
University of Michigan Rogel Cancer Center
City of Hope Medical Center
Chang Gung Memorial Hospital
Technische Universität Dresden